Generic Competitor Files With FDA For Eli Lilly and Company’s Cialis

NEW YORK -(Dow Jones)- An unnamed company has filed a generic drug application for Eli Lilly & Co.'s (LLY) erectile dysfunction drug Cialis, according to the U.S. Food and Drug Administration's Web site.